Ironwood Pharma Upped to Strong Buy – Analyst Blog

By | January 3, 2013
0 Comment

On January 2, 2013, Zacks Investment Research upgraded Ironwood Pharmaceuticals, Inc.’s ( IRWD ) to a Zacks #1 Rank (Strong Buy). Why the Upgrade

More:
Ironwood Pharma Upped to Strong Buy – Analyst Blog

Related posts:

  1. Ironwood Pharma Beats on All Fronts – Analyst Blog
  2. Juniper Networks: A Strong Buy – Analyst Blog
  3. Micron Upgraded to Strong Buy – Analyst Blog
  4. American Public Upgraded to Strong Buy – Analyst Blog